Livingston, NJ, United States of America

Zhengmao Li

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Inventor Zhengmao Li from Livingston, NJ**

Introduction

Zhengmao Li is an accomplished inventor based in Livingston, New Jersey, with a notable contribution to the field of pharmaceuticals. With a total of two patents to his name, he has made significant strides in developing innovative pharmaceutical compositions.

Latest Patents

Zhengmao Li's most recent patents include advancements in pharmaceutical compositions featuring the compound (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione. These compositions are primarily aimed at oral dosage formulations. The patents detail methods of preparation and usage of these pharmaceutical compositions, which include a carrier or diluent alongside the active ingredient.

Career Highlights

Zhengmao Li is currently associated with Celgene Corporation, where he contributes his expertise in the pharmaceutical industry. His work at Celgene has allowed him to collaborate with other talented professionals, furthering the reach of innovative pharmaceutical solutions.

Collaborations

Throughout his career, Zhengmao has had the opportunity to work alongside accomplished colleagues, including Sreenivas S. Bhat and Fabien Boulineau. These collaborations have played a crucial role in enhancing the development of their patents and exploring new avenues in pharmaceutical research.

Conclusion

With a solid background in pharmaceutical compositions and significant patents under his belt, Zhengmao Li represents the innovative spirit in the field of pharmaceuticals. His ongoing contributions not only advance medical science but also inspire future innovations in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…